Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118650132 | 11865013 | 2 | F | 20160912 | 20151223 | 20160915 | PER | US-PFIZER INC-2015410060 | PFIZER | 75.00 | YR | F | Y | 0.00000 | 20160915 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118650132 | 11865013 | 1 | PS | HYDROMORPHONE HYDROCHLORIDE. | HYDROMORPHONE HYDROCHLORIDE | 1 | UNK | U | 74598 | ||||||||||
118650132 | 11865013 | 2 | SS | MORPHINE SULFATE. | MORPHINE SULFATE | 1 | UNK | U | 19999 | ||||||||||
118650132 | 11865013 | 3 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | 500 MG, AS NEEDED (500 MG, EVERY 6 HOURS, FREQ: AS NEEDED) | 0 | 500 | MG | TABLET | |||||||
118650132 | 11865013 | 4 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, DAILY | 0 | 10 | MG | TABLET | |||||||
118650132 | 11865013 | 5 | C | CARAFATE | SUCRALFATE | 1 | Oral | 1 G, 4X/DAY | 0 | 1 | G | TABLET | QID | ||||||
118650132 | 11865013 | 6 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | UNK, DAILY | 0 | ||||||||||
118650132 | 11865013 | 7 | C | COQ 10 | UBIDECARENONE | 1 | Oral | UNK, DAILY | 0 | ||||||||||
118650132 | 11865013 | 8 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 1 DF, 1X/DAY (EVERY MORNING BEFORE BREAKFAST) | 0 | 1 | DF | CAPSULE | QD | ||||||
118650132 | 11865013 | 9 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, UNK (PATIENT TAKING DIFFERENTLY, FREQ: 2 DAY; INTERVAL: 1) | 0 | 40 | MG | CAPSULE | |||||||
118650132 | 11865013 | 10 | C | FLAXSEED | FLAX SEED | 1 | Oral | UNK, DAILY | 0 | ||||||||||
118650132 | 11865013 | 11 | C | NORCO | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 1 DF, AS NEEDED (EVERY 6 HOURS, FREQ: AS NEEDED) | 0 | 1 | DF | TABLET | |||||||
118650132 | 11865013 | 12 | C | FEMARA | LETROZOLE | 1 | Oral | 1 DF, DAILY | 0 | 1 | DF | TABLET | |||||||
118650132 | 11865013 | 13 | C | EMLA | LIDOCAINEPRILOCAINE | 1 | UNK (APPLY TO MEDI PORT SITE 30 MINUTES PRIOR TO ACCESS) | 0 | CREAM | ||||||||||
118650132 | 11865013 | 14 | C | HYZAAR | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | Oral | 1 DF, DAILY | 0 | 1 | DF | TABLET | |||||||
118650132 | 11865013 | 15 | C | IBRANCE | PALBOCICLIB | 1 | Oral | 1 DF, DAILY (DAILY WITH BREAKFAST THREE OUT OF EVERY FOUR WEEKS) | 0 | 1 | DF | ||||||||
118650132 | 11865013 | 16 | C | ZOLOFT | SERTRALINE HYDROCHLORIDE | 1 | Oral | 1 DF, 1X/DAY | 0 | 1 | DF | TABLET | QD | ||||||
118650132 | 11865013 | 17 | C | PROBIOTIC | PROBIOTICS NOS | 1 | Oral | UNK, 2X/DAY | 0 | BID | |||||||||
118650132 | 11865013 | 18 | C | MULTIVITAMIN + MINERAL | 2 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
118650132 | 11865013 | 3 | Pain |
118650132 | 11865013 | 11 | Pain |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
118650132 | 11865013 | Nausea | |
118650132 | 11865013 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |